InQ Biosciences is a biotechnology startup that offers an integrated cell growth and analysis system ideal for cellular research. The company was founded in 2007 and received a $510.00K Venture Round investment on 02 March 2010. Its product line focuses on providing a simulated in vivo environment for studying sensitive human and animal cells for disease research, particularly in the fields of neuroscience, stem cell research, cancer biology, and cardiovascular studies.
The company's slogan "Empowering breakthroughs in cellular research with sophisticated, automated technology for advanced cell and tissue growth and analysis" reflects its dedication to advancing the field. The InQ system combines software-controlled sample management with imaging and real-time data collection for cell and tissue research, offering features such as automated microscopy with remote monitoring for detailed cell analysis and visualization. Moreover, it precisely manages temperature, gas levels, media perfusion, and pressure to support extended cell growth, simulating the human body's environment.
With a focus on Biotechnology, Health and Wellness, Platforms, InQ Biosciences aims to revolutionize cellular research and analysis by providing advanced and automated technology for cell and tissue growth.
Funding Stage | Amount | No. Investors | Investors | Date |
---|---|---|---|---|
Venture Round | $510.00K | - | 02 Mar 2010 |
No recent news or press coverage available for InQ Biosciences.